Clinical Trial Update: Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement

View source ↗

Summary

This clinical trial update assesses whether tryptase levels can serve as a biomarker for complications after transcatheter aortic valve replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Transcatheter Aortic Valve Implantation Prosnosis and Complications | Status: UNKNOWN